-
NMPA Issued the Announcement on Issues Pertaining to the Current Administration on Drug Distribution
2020-04-03
On April 3, 2020, NMPA issued the Announcement on Issues Pertaining to the Current Administration on Drug Distribution.
-
NMPA Issued the Announcement on Issues Pertaining to the Implementation of the Newly Revised Provisions for the Supervision and Administration of Drug Production
2020-03-31
On March 31, 2020, NMPA issued the Announcement on Issues Pertaining to the Implementation of the Newly Revised Provisions for the Supervision and Administration of Drug Production (No. 47 of 2020).
-
NMPA Announcement on Issues Pertaining to the Implementation of the Provisions for Drug Registration
2020-03-31
On March 31, 2020, NMPA issued the Announcement on Issues Pertaining to the Implementation of the Provisions for Drug Registration (No. 46 of 2020).
-
SAMR Promulgates the Provisions for Drug Registration and Provisions for the Supervision and Administration of Drug Production
2020-03-30
On March 30, the State Administration for Market Regulation (SAMR) promulgated the Provisions for Drug Registration by Order No. 27, and the Provisions for the Supervision and Administration of Drug Production by Order No. 28, which shall be officially implemented from July 1, 2020.
-
NMPA Issued the Administrative Measures for Sampling Inspection of Medical Device Quality
2020-03-13
NMPA has organized the revision of and released on March 13, 2020 the Administrative Measures for Sampling Inspection of Medical Device Quality.
-
NMPA Issued the Guidelines for the Verification of Medical Device Registration Quality Management System
2020-03-17
NMPA has organized the formulation of and released on March 17, 2020 the Guidelines for Medical Device Registration Quality Management System Verification.